ORYZON to Present at the 13th Annual Discovery on target: Targeting Histone Methyltransferases and Demethylases meeting in BOSTON

Oryzon, a clinical stage epigenetic biopharmaceutical company, today announced that it will be presenting at the13th Annual Discovery on target: Targeting Histone Methyltransferases and Demethylases meeting to be held at the Hotel Westin-Boston Waterfront in Boston, Massachusetts on September 22-23.

Click here to see the full Press Release.